Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eyevensys SA

Latest From Eyevensys SA

Finance Watch: New Funding Available For Antibacterials, Start-Ups

Private Company Edition: The Novo Holdings Repair Impact Fund wants to fund another round of antimicrobial resistance efforts. Also, Atlas Venture raised a new $400m fund, Everest closed a $310m series C round and Cognition received a $78.5m grant.

Business Strategies Commercial

Boehringer Ingelheim Is Getting Bets In Early In IO Space

The head of the German family-owned firm's venture fund tells Scrip that investing very early in promising start-ups gives Boehringer Ingelheim "a little bit of a head start" on rival pharma companies in identifying technologies that could translate into therapies five years down the line .

Financing M & A

Appointments: Eli Lilly, Cell Medica, Exscientia, Achaogen, Eyevensys, Tessa Therapeutics, EMD Serono, TapImmune, Cue Biopharma

The latest biopharma industry appointments include a key hire for Eli Lilly's oncology R&D team, a new chief executive for Achaogen, an ex-rugby star joining Exscientia and the appointment of a well-known industry figure to the board at Cell Medica.

Appointments BioPharmaceutical

Execs On The Move, April 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Eyevensys SA
  • Senior Management
  • Patricia Zilliox, PhD, CEO
    Francine Behar-Cohen, MD, PhD, CSO
    Ronald R Buggage, MD, CMO
  • Contact Info
  • Eyevensys SA
    Phone: (0)1 84 79 10 60
    11 rue Watt
    Paris, 75013